Reported valuation; nothing comparable since.
- ·1 fund mark: filer, period, implied $/share
Membership and data by Private Market View
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Odyssey Therapeutics funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Later Stage VC | $214.0M | ▮ | ▮ |
| Oct 2023 | Later Stage VC | $117.2M | ▮ | ▮ |
| Oct 2022 | Early Stage VC (Series B) | $168.0M | ▮ | ▮ |
| Aug 2021 | Later Stage VC | $91.6M | ▮ | ▮ |
Membership and data by Private Market View
Odyssey Therapeutics valuation
Odyssey Therapeutics is valued at approximately $638 million as of Oct 2026. The figure is set by institutional fund marks.
How much has Odyssey Therapeutics raised?
Odyssey Therapeutics has raised $716 million across 4 recorded rounds since 2021. The largest was a $91.6 million later-stage round in Aug 2021; the most recent was a $214 million later-stage round in Jun 2025.
Odyssey Therapeutics has filed 5 Form Ds with the SEC since 2021, most recently in Dec 2025 ($214 million sold to 55 investors).
Institutional holders and vehicles
1 SEC-registered fund reported 1 fair-value mark on Odyssey Therapeutics for May 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
Comparable companies
Comparable biotechnology names by valuation on PrivateMarketView: Cardurion ($760 million), DNA Script ($660 million) and bit.bio ($546 million).
How Odyssey Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Odyssey Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about Odyssey Therapeutics
- What is Odyssey Therapeutics worth?
- Odyssey Therapeutics is valued at $638.2M as of Oct 2026. Reported valuation; nothing comparable since.
- How much has Odyssey Therapeutics raised?
- Odyssey Therapeutics has raised $716.2M in total funding across 4 recorded rounds.
- When did Odyssey Therapeutics last raise?
- Odyssey Therapeutics last raised in Jun 2025 (Later Stage VC), raising $214.0M.